Anxiety is a severe problem for at least one-third of people living with Parkinson's disease (PD). Anxiety appears to have a greater adverse impact on quality of life than motor impairment. Despite its high prevalence and impact on daily life, anxiety is often undiagnosed and untreated. To better address anxiety in PD, future research must improve knowledge about the mechanism of anxiety in PD and address the lack of empirical evidence from clinical trials. In response to these challenges, the Parkinson's Foundation sponsored an expert meeting on anxiety on June 13th and 14th 2018. This paper summarizes the findings from that meeting informed by a review of the existing literature and discussions among patients, caregivers, and an international, clinician-scientist, expert panel working group. The goal is to provide recommendations to improve our understanding and treatment of anxiety in PD.

中文翻译：

---

关于焦虑作为帕金森病的非运动表现的多学科会议的报告。

对于至少三分之一的帕金森病 (PD) 患者来说，焦虑是一个严重的问题。焦虑对生活质量的不利影响似乎比运动障碍更大。尽管焦虑症发病率很高并且对日常生活有影响，但它常常未被诊断和治疗。为了更好地解决帕金森病焦虑问题，未来的研究必须提高对帕金森病焦虑机制的认识，并解决临床试验经验证据的缺乏。为了应对这些挑战，帕金森病基金会于 2018 年 6 月 13 日至 14 日主办了一次关于焦虑的专家会议。本文总结了该会议的研究结果，该会议回顾了现有文献以及患者、护理人员和国际临床医生之间的讨论-科学家、专家小组工作组。目的是提供建议，以提高我们对帕金森病焦虑的理解和治疗。